The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

Shares of NYSE GMED opened at $73.35 on Tuesday. Globus Medical has a twelve month low of $49.33 and a twelve month high of $94.93. The firm has a fifty day simple moving average of $84.13 and a ...

Globus Medical (NYSE:GMED – Get Free Report)‘s stock had its “hold” rating restated by equities researchers at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports.

In the preceding three months, 5 analysts have released ratings for Globus Medical (NYSE:GMED), presenting a wide array of perspectives from bullish to bearish. The table below summarizes their ...

If you’re on the fence about investing in Globus Medical, Inc. or QuidelOrtho Corporation because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

If you’re on the fence about investing in Globus Medical, Inc., TransMedics Group or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making ...

Get the latest medical device business news, application and technology trends. DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges ...

Join Globus at booth #2517 to learn about the comprehensive Globus Medical product portfolio across ... and surgeon-centric design while allowing customization of workflow for surgeon preferences ...

Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Globus Medical (NYSE:GMED) and its peers. The medical ...

AUSTIN, Texas, March 11, 2025 /PRNewswire/ -- OsteoCentric Technologies, a global leader in innovative medical technologies, announced it has entered into a non-exclusive licensing agreement with ...